ADVANCED BIOMED INC (ADVB) Stock Income Statement
USA - NASDAQ:ADVB - US00752P1049 - Common Stock
0.44 USD
0 (0%)
0.433 USD
-0.01 (-1.59%)
| TTM (2025-3-31) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | ||||
|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 4.35M | 2.54M | 3.07M | 2.37M | |||
| Research and Development | 1.56M | 880.20K | 1.38M | 1.62M | |||
| Selling, General, and Administrative Expenses | 2.79M | 1.66M | 1.69M | 754.80K | |||
| Operating Income | -4.35M | -2.54M | -3.07M | -2.37M | |||
| Interest Income/Expense | -961.20K | -241.20K | -490.20K | 200.00 | |||
| Other Income/Expense | -29.00K | 500.00 | -21.10K | -35.60K | |||
| Non Recurring Items | N/A | 0.00 | -150.20K | -1.62M | |||
| Income Before Taxes | -5.34M | -2.78M | -3.73M | -4.03M | |||
| Income Tax | N/A | N/A | N/A | 0.00 | |||
| Net Income | -5.34M | -2.78M | -3.73M | -4.03M | |||
| EBITDA | -3.83M | -2.14M | -2.71M | -2.25M | |||
| Per Share Data | |||||||
| EPS Diluted Total Ops | -0.25 | -0.13 | -0.17 | -0.19 | |||
| Statistics | |||||||
All data in USD